Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-15

Clinical Trial Update: A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD [NA]

View source ↗

Summary

A clinical trial is evaluating the safety and efficacy of a new light-based combination therapy for intermediate-stage age-related macular degeneration and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • New Light Combination Therapy

Snippet

Sponsor: Oculox Technologies SA | Conditions: Intermediate AMD | NA | Status: RECRUITING